1933 Industries (TGIF) AI Stock Analysis

1933 Industries

(CNQX:TGIF)

Select Model

Rating:47Neutral

Price Target:CAD 0.01▲(0.00% Upside)

Action:reiterated

Date:07/01/26

Weak balance sheet with negative equity and declining assets drives the low score, offset somewhat by improving profitability and cash flow; bearish technicals and modest valuation add caution in the specialty drug sector.

Positive Factors

Improving cash generationConsistent positive free cash flow and operating cash flow indicate the business can internally fund some operations and capital needs. This strengthens near-term self-financing ability, supports earnings quality, and reduces absolute reliance on external financing if cash conversion momentum stabilizes.

Negative Factors

Weak balance sheet / negative equityNegative equity and sizable debt relative to assets materially constrain financial flexibility and increase solvency risk. This structure leaves the company vulnerable to cash-flow volatility, limits ability to raise unsecured capital, and raises default or restructuring risk if performance weakens.

1933 Industries (TGIF) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 5.21M
Dividend Yield: ―
Average Volume (3M): 221.23K
Price to Earnings (P/E): 6.3
Beta (1Y): -1.77
Revenue Growth: -4.90%
EPS Growth: ―
Country: Canada
Employees: 85
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

1933 Industries Business Overview & Revenue Model

Company Description

1933 Industries Inc. is a Vancouver, Canada-based cannabis company engaged in the cultivation and production of cannabis products throughout the United States and Canada. The firm develops, packages, and markets an extensive range of cannabidiol (CBD...

How the Company Makes Money

1933 Industries makes money primarily by selling cannabis products through regulated, state-licensed cannabis supply chains. Key revenue streams include: (1) wholesale and/or direct sales of company-produced cannabis products (including manufactured/...

1933 Industries Financial Statement Overview

Summary

Averaging income statement (55) with positive profitability trajectory, weak balance sheet (25) showing negative equity and declining assets, and improving cash flow (65) with positive generation, resulting in a low-moderate score reflecting recovery offset by high financial risks.

Income Statement

55Neutral

Balance Sheet

25Negative

Cash Flow

65Positive

Financial statement breakdown
Breakdown	TTM	Oct 2025	Jan 2025	Oct 2023	Oct 2022	Oct 2021
Income Statement
Total Revenue	16.51M	17.45M	19.35M	18.27M	12.54M	11.98M
Gross Profit	169.46K	5.16M	2.94M	-4.22M	2.69M	4.82M
EBITDA	-2.02M	1.01M	313.67K	-10.03M	-13.83M	-2.71M
Net Income	468.28K	-217.04K	-1.14M	-13.36M	-18.07M	-6.29M
Balance Sheet
Total Assets	15.53M	16.80M	16.87M	18.02M	29.01M	45.35M
Cash, Cash Equivalents and Short-Term Investments	536.57K	545.98K	449.18K	1.09M	363.27K	4.41M
Total Debt	15.57M	17.60M	16.78M	17.57M	17.68M	17.87M
Total Liabilities	18.80M	21.40M	21.70M	23.28M	21.49M	20.12M
Stockholders Equity	-3.27M	-4.60M	-3.53M	-3.69M	8.52M	25.99M
Cash Flow
Free Cash Flow	1.91M	1.67M	801.71K	-2.33M	-5.10M	-5.12M
Operating Cash Flow	2.08M	1.84M	1.69M	-1.53M	-5.09M	-4.67M
Investing Cash Flow	-318.84K	-169.22K	-890.78K	2.33M	1,581	-456.36K
Financing Cash Flow	-2.02M	-1.58M	-1.46M	-266.55K	1.53M	6.06M

1933 Industries Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:TGIF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:TGIF	47Neutral	CAD 5.21M	6.25	-11.60%	―	-4.90%	―
TSE:BBM	45Neutral	CAD 7.43M	-7.14	-332.63%	―	-36.67%	40.54%
TSE:DHB	43Neutral	CAD 2.34M	-2.31	-26.42%	―	-35.46%	-85.82%
TSE:PCLO	24Underperform	CAD 9.34M	-2.67	28.59%	―	0.90%	57.73%

* Healthcare Sector Average

Performance Comparison

TSE:TGIF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:TGIF	1933 Industries, Inc.	0.01	0.00	0.00%
TSE:DHB	Delivra Health Brands Inc.	0.07	-0.21	-74.14%
TSE:BBM	Blueberries Medical	0.01	-0.01	-25.00%
TSE:PCLO	Pharmacielo	0.05	0.01	11.11%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jul 01, 2026

1933 Industries AI Stock Analysis